These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 16955633)

  • 1. Recent advances in the investigation of lipoprotein metabolism using tracer methodology.
    Chan DC; Watts GF
    Clin Lab; 2006; 52(7-8):353-61. PubMed ID: 16955633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein transport in the metabolic syndrome: methodological aspects of stable isotope kinetic studies.
    Chan DC; Barrett PH; Watts GF
    Clin Sci (Lond); 2004 Sep; 107(3):221-32. PubMed ID: 15225121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic studies to investigate lipoprotein metabolism.
    Borén J; Taskinen MR; Adiels M
    J Intern Med; 2012 Feb; 271(2):166-73. PubMed ID: 22142374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic regulation of apoB100 metabolism in insulin resistance in vivo.
    Watts GF; Ooi EM; Chan DC
    Pharmacol Ther; 2009 Sep; 123(3):281-91. PubMed ID: 19490928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent studies of lipoprotein kinetics in the metabolic syndrome and related disorders.
    Chan DC; Barrett PH; Watts GF
    Curr Opin Lipidol; 2006 Feb; 17(1):28-36. PubMed ID: 16407713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome.
    Adiels M; Olofsson SO; Taskinen MR; Borén J
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1225-36. PubMed ID: 18565848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms for therapeutic correction of dyslipidaemia in insulin resistance and diabetes.
    Watts GF; Chan DC
    Atheroscler Suppl; 2010 Jun; 11(1):61-4. PubMed ID: 20452838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein transport in the metabolic syndrome: pathophysiological and interventional studies employing stable isotopy and modelling methods.
    Chan DC; Barrett PH; Watts GF
    Clin Sci (Lond); 2004 Sep; 107(3):233-49. PubMed ID: 15225143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein C-III: understanding an emerging cardiovascular risk factor.
    Ooi EM; Barrett PH; Chan DC; Watts GF
    Clin Sci (Lond); 2008 May; 114(10):611-24. PubMed ID: 18399797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease.
    Lara-Castro C; Fu Y; Chung BH; Garvey WT
    Curr Opin Lipidol; 2007 Jun; 18(3):263-70. PubMed ID: 17495599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fish oils, phytosterols and weight loss in the regulation of lipoprotein transport in the metabolic syndrome: lessons from stable isotope tracer studies.
    Watts GF; Chan DC; Ooi EM; Nestel PJ; Beilin LJ; Barrett PH
    Clin Exp Pharmacol Physiol; 2006 Sep; 33(9):877-82. PubMed ID: 16922825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stable isotope tracer dilution for quantifying very low-density lipoprotein-triacylglycerol kinetics in man.
    Sidossis LS; Magkos F; Mittendorfer B; Wolfe RR
    Clin Nutr; 2004 Aug; 23(4):457-66. PubMed ID: 15297080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipodystrophy: lessons in lipid and energy metabolism.
    Simha V; Garg A
    Curr Opin Lipidol; 2006 Apr; 17(2):162-9. PubMed ID: 16531753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action of niacin.
    Kamanna VS; Kashyap ML
    Am J Cardiol; 2008 Apr; 101(8A):20B-26B. PubMed ID: 18375237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome.
    Chan DC; Watts GF; Ng TW; Yamashita S; Barrett PH
    Eur J Clin Invest; 2008 Oct; 38(10):743-51. PubMed ID: 18837799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary plant sterols supplementation does not alter lipoprotein kinetics in men with the metabolic syndrome.
    Ooi EM; Watts GF; Barrett PH; Chan DC; Clifton PM; Ji J; Nestel PJ
    Asia Pac J Clin Nutr; 2007; 16(4):624-31. PubMed ID: 18042521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thematic review series: patient-oriented research. Design and analysis of lipoprotein tracer kinetics studies in humans.
    Barrett PH; Chan DC; Watts GF
    J Lipid Res; 2006 Aug; 47(8):1607-19. PubMed ID: 16728729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis.
    Kontush A; Chapman MJ
    Pharmacol Rev; 2006 Sep; 58(3):342-74. PubMed ID: 16968945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pioglitazone on lipid and lipoprotein metabolism.
    Betteridge DJ
    Diabetes Obes Metab; 2007 Sep; 9(5):640-7. PubMed ID: 17697057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid and lipoprotein profiles and prevalence of dyslipidemia in Mexican adolescents.
    Posadas-Sánchez R; Posadas-Romero C; Zamora-González J; Mendoza-Pérez E; Cardoso-Saldaña G; Yamamoto-Kimura L
    Metabolism; 2007 Dec; 56(12):1666-72. PubMed ID: 17998019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.